Masimo (MASI) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Masimo Revenue Highlights


Latest Revenue (Y)

$2.05B

Latest Revenue (Q)

$492.80M

Main Segment (Y)

Health Care Segment

Main Geography (Y)

UNITED STATES

Masimo Revenue by Period


Masimo Revenue by Year

DateRevenueChange
2023-12-30$2.05B0.60%
2022-12-31$2.04B64.29%
2022-01-01$1.24B8.34%
2021-01-02$1.14B21.96%
2019-12-28$937.84M9.27%
2018-12-29$858.29M7.54%
2017-12-30$798.11M14.90%
2016-12-31$694.63M10.24%
2016-01-02$630.11M7.41%
2015-01-03$586.64M7.20%
2013-12-28$547.25M10.95%
2012-12-29$493.23M12.36%
2011-12-31$438.99M8.28%
2011-01-01$405.41M16.12%
2010-01-02$349.12M13.69%
2009-01-03$307.07M19.82%
2007-12-29$256.29M14.24%
2006-12-31$224.34M107.93%
2005-12-31$107.89M55.56%
2004-12-31$69.36M48.41%
2003-12-31$46.73M20.35%
2002-12-31$38.83M479.58%
1999-12-31$6.70M294.12%
1998-12-31$1.70M-

Masimo generated $2.05B in revenue during NA 2023, up 0.60% compared to the previous quarter, and up 238.63% compared to the same period a year ago.

Masimo Revenue by Quarter

DateRevenueChange
2024-03-30$492.80M-10.22%
2023-12-30$548.90M14.62%
2023-09-30$478.90M5.18%
2023-07-01$455.30M-19.42%
2023-04-01$565.00M-8.43%
2022-12-31$617.00M12.32%
2022-10-01$549.30M-2.83%
2022-07-02$565.30M85.81%
2022-04-02$304.24M-7.12%
2022-01-01$327.58M6.56%
2021-10-02$307.41M0.75%
2021-07-03$305.12M2.03%
2021-04-03$299.04M1.35%
2021-01-02$295.05M6.09%
2020-09-26$278.11M-7.59%
2020-06-27$300.95M11.62%
2020-03-28$269.63M8.93%
2019-12-28$247.51M8.08%
2019-09-28$229.01M-0.28%
2019-06-29$229.65M-0.87%
2019-03-30$231.66M3.82%
2018-12-29$223.13M5.96%
2018-09-29$210.58M-0.49%
2018-06-30$211.62M-0.63%
2018-03-31$212.95M-5.43%
2017-12-30$225.18M16.26%
2017-09-30$193.69M0.39%
2017-07-01$192.93M3.56%
2017-04-01$186.30M1.69%
2016-12-31$183.20M9.29%
2016-10-01$167.62M-2.90%
2016-07-02$172.64M0.86%
2016-04-02$171.17M2.33%
2016-01-02$167.27M9.63%
2015-10-03$152.57M-2.02%
2015-07-04$155.73M0.77%
2015-04-04$154.54M-4.48%
2015-01-03$161.79M12.26%
2014-09-27$144.12M2.27%
2014-06-28$140.92M0.79%
2014-03-29$139.81M-1.84%
2013-12-28$142.43M8.36%
2013-09-28$131.45M-4.35%
2013-06-29$137.42M1.09%
2013-03-30$135.94M2.86%
2012-12-29$132.16M11.00%
2012-09-29$119.07M-3.02%
2012-06-30$122.78M2.97%
2012-03-31$119.23M6.13%
2011-12-31$112.34M7.98%
2011-10-01$104.04M-5.04%
2011-07-02$109.56M-3.08%
2011-04-02$113.04M7.07%
2011-01-01$105.57M4.54%
2010-10-02$100.99M0.91%
2010-07-03$100.08M1.33%
2010-04-03$98.77M6.64%
2010-01-02$92.61M5.91%
2009-10-03$87.44M4.63%
2009-07-04$83.57M-2.25%
2009-04-04$85.49M2.92%
2009-01-03$83.07M6.31%
2008-09-27$78.13M4.50%
2008-06-28$74.77M5.14%
2008-03-29$71.11M2.65%
2007-12-29$69.28M-

Masimo generated $492.80M in revenue during Q1 2024, up -10.22% compared to the previous quarter, and up 79.87% compared to the same period a year ago.

Masimo Revenue Breakdown


Masimo Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22
Health Care Segment$1.28B$1.34B

Masimo's latest annual revenue breakdown by segment (product or service), as of Dec 23: Health Care Segment (100.00%).

Quarterly Revenue by Product

Product/ServiceMar 24Dec 23Sep 23Jul 23Apr 23Dec 22Oct 22Jul 22
Health Care Segment$339.60M$339.90M$307.80M$281.10M$346.70M$351.80M$327.20M-
Healthcare-------$357.00M

Masimo's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Health Care Segment (100.00%).

Masimo Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22Jan 22Jan 21Dec 19
Americas$66.40M$43.70M$41.31M$38.24M$28.71M
EMEA$571.90M$523.60M$251.84M$238.68M$183.36M
Asia Pacific$351.00M$326.80M$123.59M$103.76M$87.96M
UNITED STATES$1.06B$1.14B$822.41M$763.07M$636.37M

Masimo's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (51.70%), EMEA (27.92%), Asia Pacific (17.14%), and Americas (3.24%).

Quarterly Revenue by Country

CountryApr 22Oct 21Jul 21Apr 21Sep 20Jun 20Mar 20Sep 19Jun 19Mar 19Sep 18Jun 18Mar 18
Americas$10.94M$9.25M$9.61M$8.32M$9.35M$11.81M$6.44M$6.19M$6.91M$7.29M$6.58M$7.04M$6.40M
Asia Pacific$34.57M$34.88M$32.42M$26.90M$27.58M$26.26M$19.31M$22.72M$21.68M$18.12M$21.33M$20.50M$12.91M
EMEA$60.95M$56.22M$61.21M$59.62M$54.26M$68.17M$54.36M$42.36M$45.41M$48.47M$37.26M$34.33M$44.05M
UNITED STATES$197.78M$207.06M$201.87M$204.20M$186.92M$194.72M$189.52M$157.65M$155.51M$156.67M$136.90M$140.13M$141.04M

Masimo's latest quarterly revenue breakdown by geography, as of Apr 22: UNITED STATES (65.01%), EMEA (20.03%), Asia Pacific (11.36%), and Americas (3.60%).

Masimo Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
DXCMDexCom$3.62B$994.20M
MASIMasimo$2.05B$492.80M
PODDInsulet$1.70B$488.50M
CNMDCONMED$1.24B$316.70M
LIVNLivaNova$1.15B$318.11M
PENPenumbra$1.06B$301.04M
TNDMTandem Diabetes Care$747.72M$331.03M
SWAVShockWave Medical$730.23M$218.81M
INSPInspire Medical Systems$624.80M$195.88M
NARIInari Medical$493.63M$153.39M
GKOSGlaukos$314.71M$95.69M
TMDXTransMedics Group$241.62M$-12.24M

MASI Revenue FAQ


Masimo's yearly revenue for 2023 was $2.05B, representing an increase of 0.60% compared to 2022. The company's yearly revenue for 2022 was $2.04B, representing an increase of 64.29% compared to 2021. MASI's yearly revenue for 2021 was $1.24B, representing an increase of 8.34% compared to 2020.

Masimo's quarterly revenue for Q1 2024 was $492.8M, a -10.22% decrease from the previous quarter (Q4 2023), and a -12.78% decrease year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $548.9M, a 14.62% increase from the previous quarter (Q3 2023), and a -11.04% decrease year-over-year (Q4 2022). MASI's quarterly revenue for Q3 2023 was $478.9M, a 5.18% increase from the previous quarter (Q2 2023), and a -12.82% decrease year-over-year (Q3 2022).

Masimo's revenue growth rate for the last 3 years (2021-2023) was 65.28%, and for the last 5 years (2019-2023) was 118.39%.

Masimo's revenue streams in c 23 are Health Care Segment

For the fiscal year ending Dec 23, the largest source of revenue of Masimo was Health Care Segment. This segment made a revenue of $1.28B, representing 100.00% of the company's total revenue.